The results of multiple immune infiltration algorithms demonstrated that the low-risk group generally had a richer infiltration of anti-tumor immune cells, such as CD8+ T cells, CD4+ T cells, active NK cells, B cells, and so on. The gene discussed is CD8A; the disease is neoplasm.